ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,306.04
0.00%
Dow Jones
38,852.86
0.00%
US Dollar vs MXN
16.88483
0.53%
Brent Oil
84.255
-0.08%
Bitcoin
67,873.66
-0.61%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. EXACT Sciences Corporation (EXAS)

  7. EXACT Sciences Corporation (EXAS) Noticias

EXAS

EXACT Sciences (EXAS)

EXACT Sciences Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:EXAS
FechaHoraFuenteTítuloSímboloCompañía
28/05/202405:00Business WireExact Sciences to Participate in June Investor ConferencesNASDAQ:EXASEXACT Sciences Corporation
25/05/202406:32Business WireASCO®: Exact Sciences bekräftigt mit mehreren Datenpräsentationen seine langfristige Vorreiterrolle in der Krebsfrüherkennung und bei der Verbesserung von BehandlungsergebnissenNASDAQ:EXASEXACT Sciences Corporation
24/05/202411:46Business WireExact Sciences démontre son leadership continu en matière de diagnostic précoce du cancer et d’amélioration des résultats pour les patients grâce à de multiples présentations de données à l’ASCO®NASDAQ:EXASEXACT Sciences Corporation
24/05/202405:05Business WireExact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®NASDAQ:EXASEXACT Sciences Corporation
22/05/202406:30Business WireExact Sciences Earns 2024 Great Place To Work® Certification™NASDAQ:EXASEXACT Sciences Corporation
21/05/202405:05Business WireCourt Ruling Enables Exact Sciences to Proceed with Lawsuit against GeneoscopyNASDAQ:EXASEXACT Sciences Corporation
20/05/202415:30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
08/05/202416:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EXASEXACT Sciences Corporation
08/05/202416:08Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:EXASEXACT Sciences Corporation
08/05/202416:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EXASEXACT Sciences Corporation
08/05/202415:05Business WireExact Sciences Announces First-Quarter 2024 ResultsNASDAQ:EXASEXACT Sciences Corporation
08/05/202407:29IH Market NewsU.S. Futures Slightly Dip Amid Corporate Earnings and Quiet Economic Calendar, Oil Prices FallNASDAQ:EXASEXACT Sciences Corporation
07/05/202407:00Business WireExact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024NASDAQ:EXASEXACT Sciences Corporation
01/05/202405:00Business WireExact Sciences to Participate in May Investor ConferenceNASDAQ:EXASEXACT Sciences Corporation
15/04/202405:00Business WireExact Sciences Names Aaron Bloomer as New Chief Financial OfficerNASDAQ:EXASEXACT Sciences Corporation
11/04/202405:00Business WireExact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior NotesNASDAQ:EXASEXACT Sciences Corporation
08/04/202411:05Business WireExact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024NASDAQ:EXASEXACT Sciences Corporation
08/04/202405:00Business WireExact Sciences Schedules First Quarter 2024 Earnings CallNASDAQ:EXASEXACT Sciences Corporation
04/04/202405:05Business WireExact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform TreatmentNASDAQ:EXASEXACT Sciences Corporation
28/03/202405:00Business WireExact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-CancerNASDAQ:EXASEXACT Sciences Corporation
27/03/202407:05Business WireExact Sciences Named 2024 Gallup Exceptional Workplace Award WinnerNASDAQ:EXASEXACT Sciences Corporation
13/03/202416:03Business WireThe New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C StudyNASDAQ:EXASEXACT Sciences Corporation
07/03/202406:59Business WireExact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon CancerNASDAQ:EXASEXACT Sciences Corporation
04/03/202419:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
01/03/202414:53Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXASEXACT Sciences Corporation
26/02/202405:00Business WireExact Sciences to Participate in March Investor ConferenceNASDAQ:EXASEXACT Sciences Corporation
21/02/202416:05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:EXASEXACT Sciences Corporation
21/02/202415:05Business WireExact Sciences Announces Fourth Quarter 2023 ResultsNASDAQ:EXASEXACT Sciences Corporation
01/02/202405:00Business WireExact Sciences Schedules Fourth Quarter 2023 Earnings CallNASDAQ:EXASEXACT Sciences Corporation
07/01/202415:30PR Newswire (US)Exact Sciences Announces Preliminary Fourth Quarter 2023 ResultsNASDAQ:EXASEXACT Sciences Corporation
 Showing the most relevant articles for your search:NASDAQ:EXAS

Su Consulta Reciente

BIT
P1PII5
BNP Paribas Issuance
BIT
P1TAD5
BNP Paribas Issuance
EU
NWSWN
Wind&Solar W NR Idx
EU
BE0002677590
Region de Bruxelles Capi...
COIN
FXCHBTC
BOV
K1SS34M
Kohl`s
ASX
GESNA
BIT
F17825
Vontobel Financial Produ...
TG
EXHA
German government
LBNK
TRADEUSDT
TRADE
TG
FLXG
Franklin Templeton ICAV
COIN
JSEETH
JSE Token
BIT
I07816
Intesa Sanpaolo
NASDAQ
AAXIUXX
Citigroup Global Markets...
BIT
F16667
Vontobel Financial Produ...
ASE
KTILA
Ktima Lazaridis
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados